Results of evaluation of neurometabolic and rehabilitation therapy for vincristine polyneuropathy in children with acute lymphoblastic leukemia

O. Koryakina, O. P. Kovtun, L. Fechina, V. V. Bazarny, A. V. Rezaikin
{"title":"Results of evaluation of neurometabolic and rehabilitation therapy for vincristine polyneuropathy in children with acute lymphoblastic leukemia","authors":"O. Koryakina, O. P. Kovtun, L. Fechina, V. V. Bazarny, A. V. Rezaikin","doi":"10.52420/2071-5943-2023-22-6-124-135","DOIUrl":null,"url":null,"abstract":"Introduction. Vincristine-induced peripheral neuropathies (VIPN) is a current problem in the management of pediatric acute lymphoblastic leukemia (ALL). There are no effective therapeutic strategies for VIPN.   The aim of the study to present the results of evaluation of neurometabolic therapy in the acute period of VIPN in children with ALL and the method of virtual rehabilitation in the recovery period.   Materials and methods. The single-center prospective comparative pilot study involved 69 children with VIPN who were treated in the acute period with the following drugs: group 1 - pyridoxine, group 2 - thioktovic acid, group 3 - inosine + nicotinamide + riboflavin + succinic acid. Clinical and electrophysiological parameters before and after drug treatment were analyzed. Among 10 children with motor deficits in the lower extremities in the recovery period of VIPN, rehabilitation with immersive virtual reality was performed, and the clinical parameters before and after the course were compared.   Results. A positive effect of the studied drugs on the clinical condition of patients by the 30th day of therapy was revealed. In groups 1 and 3 the total score on the NIS-LL scale correlated with mild polyneuropathy - 4 [2÷8] and 2 [2÷6] points, respectively. Neurologic impairment in each of these groups persisted for 19 [14÷25] and 19 [13÷30] days, which was less in contrast to the duration of symptoms in group 2 (p1-2 = 0.021 and p2-3 = 0.046). In the VIPN recovery period before and after virtual rehabilitation: muscle strength in the lower limbs increased (p = 0.025); the severity of polyneuropathy decreased according to the NIS-LL scale (p = 0.003); balance improved according to the Berg scale (p = 0.017); and patients’ mobility increased according to the Functional Walking Category test (p = 0.025) and walking speed according to the time-recorded walking test (p = 0.008).   Discussion. Improvement of clinical parameters with neurometabolic therapy and virtual rehabilitation in children with VIPN has been shown.   Conclusion. Preliminary results of the effectiveness of pyridoxine and inosine + nicotinamide + riboflavin + succinic acid in the acute period of VIPN in children with ALL and the method of virtual rehabilitation in the recovery period were obtained.","PeriodicalId":247511,"journal":{"name":"Ural Medical Journal","volume":"2019 41","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ural Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52420/2071-5943-2023-22-6-124-135","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Vincristine-induced peripheral neuropathies (VIPN) is a current problem in the management of pediatric acute lymphoblastic leukemia (ALL). There are no effective therapeutic strategies for VIPN.   The aim of the study to present the results of evaluation of neurometabolic therapy in the acute period of VIPN in children with ALL and the method of virtual rehabilitation in the recovery period.   Materials and methods. The single-center prospective comparative pilot study involved 69 children with VIPN who were treated in the acute period with the following drugs: group 1 - pyridoxine, group 2 - thioktovic acid, group 3 - inosine + nicotinamide + riboflavin + succinic acid. Clinical and electrophysiological parameters before and after drug treatment were analyzed. Among 10 children with motor deficits in the lower extremities in the recovery period of VIPN, rehabilitation with immersive virtual reality was performed, and the clinical parameters before and after the course were compared.   Results. A positive effect of the studied drugs on the clinical condition of patients by the 30th day of therapy was revealed. In groups 1 and 3 the total score on the NIS-LL scale correlated with mild polyneuropathy - 4 [2÷8] and 2 [2÷6] points, respectively. Neurologic impairment in each of these groups persisted for 19 [14÷25] and 19 [13÷30] days, which was less in contrast to the duration of symptoms in group 2 (p1-2 = 0.021 and p2-3 = 0.046). In the VIPN recovery period before and after virtual rehabilitation: muscle strength in the lower limbs increased (p = 0.025); the severity of polyneuropathy decreased according to the NIS-LL scale (p = 0.003); balance improved according to the Berg scale (p = 0.017); and patients’ mobility increased according to the Functional Walking Category test (p = 0.025) and walking speed according to the time-recorded walking test (p = 0.008).   Discussion. Improvement of clinical parameters with neurometabolic therapy and virtual rehabilitation in children with VIPN has been shown.   Conclusion. Preliminary results of the effectiveness of pyridoxine and inosine + nicotinamide + riboflavin + succinic acid in the acute period of VIPN in children with ALL and the method of virtual rehabilitation in the recovery period were obtained.
急性淋巴细胞白血病患儿长春新碱多发性神经病的神经代谢和康复治疗评估结果
简介。长春新碱诱发的周围神经病(VIPN)是目前治疗小儿急性淋巴细胞白血病(ALL)的一个难题。目前尚无针对 VIPN 的有效治疗策略。 本研究旨在介绍神经代谢疗法在儿童急性淋巴细胞白血病(ALL)VIPN急性期的评估结果以及恢复期的虚拟康复方法。 材料和方法。这项单中心前瞻性比较试验研究涉及69名VIPN患儿,他们在急性期接受了以下药物治疗:第1组--吡哆醇,第2组--硫代托维酸,第3组--肌苷+烟酰胺+核黄素+琥珀酸。对药物治疗前后的临床和电生理参数进行了分析。对10名在VIPN恢复期出现下肢运动障碍的儿童进行了沉浸式虚拟现实康复治疗,并对治疗前后的临床参数进行了比较。 结果显示在治疗的第 30 天,研究药物对患者的临床状况产生了积极影响。在第 1 组和第 3 组中,NIS-LL 量表的总分与轻度多发性神经病相关,分别为 4 [2÷8] 分和 2 [2÷6] 分。这两组患者的神经功能损害分别持续了 19 [14÷25] 天和 19 [13÷30] 天,与第 2 组的症状持续时间相比(p1-2 = 0.021 和 p2-3 = 0.046)较短。在虚拟康复前后的 VIPN 恢复期:下肢肌力增加(p = 0.025);根据 NIS-LL 量表,多发性神经病的严重程度降低(p = 0.003);根据 Berg 量表,平衡能力提高(p = 0.017);根据功能性步行分类测试,患者的活动能力提高(p = 0.025),根据时间记录步行测试,患者的步行速度提高(p = 0.008)。 讨论通过神经代谢疗法和虚拟康复治疗,VIPN患儿的临床指标有所改善。 结论吡哆醇和肌苷+烟酰胺+核黄素+琥珀酸在急性期VIPN对ALL患儿的疗效以及在恢复期的虚拟康复方法取得了初步结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信